Häring H, Kirsch D, Obermaier B, Ermel B, Machicao F
Biochem J. 1986 Feb 15;234(1):59-66. doi: 10.1042/bj2340059.
Catecholamine treatment of isolated rat adipocytes decreases insulin binding and inhibits insulin stimulation of the glucose-transport system. There is increasing evidence that the insulin signal is transmitted after insulin is bound to the receptor via a tyrosine kinase, which is an intrinsic part of the receptor. To find whether the receptor kinase is modified by catecholamines, we solubilized and partially purified the insulin receptor of isoprenaline-treated adipocytes and studied the effect of insulin on its kinase activity. (1) Insulin increased the tyrosine autophosphorylation of the insulin receptor kinase from catecholamine-treated cells only 4-fold, compared with a 12-fold stimulation in control cells. (2) The rate of insulin-stimulated 32P incorporation into the receptor of isoprenaline-treated cells at non-saturating [32P]ATP concentrations (5 muM) was decreased to 5-8% of the values for receptor from control cells. (3) 125I-insulin binding to the partially purified receptor from catecholamine-treated cells was also markedly decreased. The insulin receptor from catecholamine treated cells bound 25-50% of the amount of insulin bound by the receptor from control cells at insulin concentrations of 10 pM-0.1 muM. Part of the impaired insulin-responsiveness of the receptor kinase of catecholamine-treated cells is therefore explained by impaired binding properties; however, an additional inhibition of the kinase activity of the insulin receptor from catecholamine-treated cells is evident. (4) This inhibition of kinase activity decreased when the concentration of [gamma-32P]ATP in the phosphorylation assay was increased. A Lineweaver-Burk analysis revealed that the Km for ATP of the receptor kinase from isoprenaline-treated cells was increased to approx. 100 muM, compared with approx. 25 muM for receptor of control cells. (5) We conclude from the data that catecholamine treatment of rat adipocytes modulates the kinase activity of the insulin receptor by increasing its Km for ATP and that this is part of the mechanism leading to insulin-resistance in these cells.
儿茶酚胺对分离的大鼠脂肪细胞的处理会降低胰岛素结合,并抑制胰岛素对葡萄糖转运系统的刺激。越来越多的证据表明,胰岛素信号在胰岛素与受体结合后通过酪氨酸激酶进行传递,酪氨酸激酶是受体的固有组成部分。为了探究受体激酶是否被儿茶酚胺修饰,我们溶解并部分纯化了异丙肾上腺素处理的脂肪细胞的胰岛素受体,并研究了胰岛素对其激酶活性的影响。(1)胰岛素仅使儿茶酚胺处理细胞的胰岛素受体激酶的酪氨酸自磷酸化增加了4倍,而对照细胞中的刺激倍数为12倍。(2)在非饱和[32P]ATP浓度(5μM)下,胰岛素刺激的32P掺入异丙肾上腺素处理细胞受体的速率降至对照细胞受体值的5-8%。(3)125I-胰岛素与儿茶酚胺处理细胞的部分纯化受体的结合也明显减少。在胰岛素浓度为10 pM-0.1μM时,儿茶酚胺处理细胞的胰岛素受体结合的胰岛素量是对照细胞受体结合量的25-50%。因此,儿茶酚胺处理细胞的受体激酶胰岛素反应性受损的部分原因是结合特性受损;然而,儿茶酚胺处理细胞的胰岛素受体激酶活性明显存在额外抑制。(4)当磷酸化测定中[γ-32P]ATP的浓度增加时,这种激酶活性抑制降低。Lineweaver-Burk分析显示,异丙肾上腺素处理细胞的受体激酶的ATP Km增加到约100μM,而对照细胞受体的约为25μM。(5)我们从数据中得出结论,儿茶酚胺对大鼠脂肪细胞的处理通过增加其对ATP的Km来调节胰岛素受体的激酶活性,这是导致这些细胞胰岛素抵抗机制的一部分。